Equity Overview
Price & Market Data
Price: $33.11
Daily Change: -$0.124 / 0.37%
Daily Range: $32.78 - $33.35
Market Cap: $0
Daily Volume: 4,980
Performance Metrics
1 Week: -1.79%
1 Month: 7.90%
3 Months: 18.18%
6 Months: 2.59%
1 Year: -12.44%
YTD: -0.20%
Details
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.